New test helps guide treatment for bone marrow transplant patients with graft vs. host disease
A new test can guide treatment for patients with graft versus host disease (GVHD), an often life-threatening complication of bone marrow and stem cell transplants, according to research from the University of Michigan.
Better way to personalize treatment for bone marrow transplant patients
Patients with fatal blood cancers like leukaemia often need bone marrow or stem cell transplants to survive. But one of the most common and serious side effects that patients face is graft vs. host disease: when a patient